Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm) is established in 2006. The institutes aim to be a Biotechnology’s Centers of Excellence by exploiting megadiversity of Malaysian natural resources for the development of new drugs. IPharm therefore has a mission to conduct world-class R&D to accelerate the discovery, development and commercialization of pharmaceutical and nutraceutical products.
IPharm was established as a centre of excellence to spearhead the NBP thrusts by delivering world class R&D in order to accelerate the discovery, development and commercialisation of pharmaceutical and nutraceutical products as well as to build the nation’s skilled human resources in Healthcare Biotechnology.
For years, IPharm has established its capacity by developing the infrastructure and human resource. An integrated multi-disciplinary drug discovery team and related technologies including molecular biology, medicinal chemistry synthesis, molecular modeling, automated high-throughput screening, animal pharmacology, pharmacokinetics, drug metabolism, and formulation studies have been develop during these years. For the coming years, IPharm will take steps to position as an integrated institute for applied research and development of new pharmaceuticals and nutraceuticals.
A team, a shared facility or an entity that provides leadership, best practices, research, support and/or training for a focus area.
The Experimental Therapeutics Centre focuses on developing and acquiring new and innovative assays for natural product development and drug discovery. Our research emphasize on high throughput cell-based and cell-free screening systems, as well as whole organism assay system. By adopting these approaches, ETC could explore the research areas such as pluripotent stem cell development, developmental pathway analysis and host-pathogen interaction.
An interdisciplinary research cooperation projects
In modern drug design pipelines, great amount of interest fall into further development of in silico screening in particularly at the initial stages of drug development cycle. In silico screening is relatively more cost effective and fast as compared to the conventional high throughput screening. This approach has gradually made inroads by their more rational approach, to expedite the drug discovery and development process.
IPharm has the expertise to investigate the structure, function, and dynamics of complex biological systems. At the interface of chemistry, biology, physics, and pharmacology, IPharm research integrates both applied and basic science components,with goals to bridge the interface between basic and clinical research.
Currently, virtual screening and molecular modelling studies on anti-obesity, anti-dengue, anti-diabetes are being explore to understand the mechanism of nteraction involved and to screen for natural and chemical compounds that could be develop into potential leads.
IPharm building complex strategically located in Halaman Bukit Gambir, Pulau Pinang beside Azman Hashim USM Sport Arena.